Decitabine (DAC), an inhibitor of DNA methylation transferase, is able to induce CXCL10 expression in tumor cells and suppress anti-tumor T-cell responses and hepatoma proliferation when administered to HCC mice (166). Here, CXCL10 is linked to neoplasm.